The 161519 TriKE was designed to bind CD16 in NK cells as well as CD19 in chronic lymphocytic leukemia (CLL) cells and induces NK cell expansion and killing via IL-15 [56]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.